Cargando…
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
SSc is a rare disease of unknown origin associated with multiple organ involvement. One of the major complications that drives the mortality of SSc patients is interstitial lung disease. The course of SSc-interstitial lung disease progression has a wide spectrum. Since the treatment is based on aggr...
Autores principales: | Bonhomme, Olivier, André, Béatrice, Gester, Fanny, de Seny, Dominique, Moermans, Catherine, Struman, Ingrid, Louis, Renaud, Malaise, Michel, Guiot, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736409/ https://www.ncbi.nlm.nih.gov/pubmed/31292645 http://dx.doi.org/10.1093/rheumatology/kez230 |
Ejemplares similares
-
Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
por: Guiot, Julien, et al.
Publicado: (2021) -
Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
por: Jacquerie, P., et al.
Publicado: (2021) -
Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p
por: Guiot, Julien, et al.
Publicado: (2020) -
A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome
por: Parzibut, Gilles, et al.
Publicado: (2021) -
Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
por: Denis, Anna, et al.
Publicado: (2022)